Dividend Assets Capital LLC Cuts Stake in Teleflex Incorporated (NYSE:TFX)

Dividend Assets Capital LLC cut its position in Teleflex Incorporated (NYSE:TFX) by 9.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,660 shares of the medical technology company’s stock after selling 800 shares during the period. Dividend Assets Capital LLC’s holdings in Teleflex were worth $1,591,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Rafferty Asset Management LLC purchased a new stake in shares of Teleflex during the first quarter worth approximately $877,000. Creative Planning raised its stake in shares of Teleflex by 69.5% in the second quarter. Creative Planning now owns 3,828 shares of the medical technology company’s stock worth $795,000 after buying an additional 1,569 shares during the last quarter. UBS Asset Management Americas Inc. raised its stake in shares of Teleflex by 118.9% in the fourth quarter. UBS Asset Management Americas Inc. now owns 72,560 shares of the medical technology company’s stock worth $11,692,000 after buying an additional 39,419 shares during the last quarter. Sit Investment Associates Inc. raised its stake in shares of Teleflex by 180.0% in the first quarter. Sit Investment Associates Inc. now owns 2,800 shares of the medical technology company’s stock worth $542,000 after buying an additional 1,800 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Teleflex during the first quarter worth approximately $2,619,000. Hedge funds and other institutional investors own 92.59% of the company’s stock.

Teleflex Incorporated (NYSE:TFX) opened at 205.34 on Monday. The stock’s 50 day moving average price is $209.41 and its 200 day moving average price is $196.91. Teleflex Incorporated has a 12-month low of $136.53 and a 12-month high of $217.97. The company has a market cap of $9.25 billion, a PE ratio of 39.27 and a beta of 1.05.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, August 3rd. The medical technology company reported $2.04 EPS for the quarter, topping the consensus estimate of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The business had revenue of $528.60 million during the quarter, compared to analysts’ expectations of $518.98 million. During the same quarter last year, the firm posted $1.89 earnings per share. The firm’s revenue was up 11.6% on a year-over-year basis. Equities research analysts anticipate that Teleflex Incorporated will post $8.28 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Tuesday, August 15th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, August 11th. This represents a $1.36 annualized dividend and a yield of 0.66%. Teleflex’s dividend payout ratio is currently 26.00%.

TRADEMARK VIOLATION WARNING: This piece of content was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://sportsperspectives.com/2017/08/14/dividend-assets-capital-llc-cuts-stake-in-teleflex-incorporated-nysetfx.html.

TFX has been the subject of a number of research reports. Barclays PLC reiterated a “buy” rating on shares of Teleflex in a research report on Monday, June 26th. Deutsche Bank AG reiterated a “buy” rating and issued a $238.00 price objective (up from $220.00) on shares of Teleflex in a research report on Wednesday, August 9th. Needham & Company LLC restated a “buy” rating on shares of Teleflex in a research report on Friday, August 4th. Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $228.00 target price for the company in a research report on Friday, June 23rd. Finally, BidaskClub lowered Teleflex from a “hold” rating to a “sell” rating in a research report on Tuesday, August 8th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $228.00.

In related news, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $208.41, for a total transaction of $41,682.00. Following the completion of the sale, the director now owns 8,080 shares of the company’s stock, valued at $1,683,952.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gretchen R. Haggerty bought 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 21st. The shares were acquired at an average cost of $203.82 per share, with a total value of $203,820.00. Following the purchase, the director now directly owns 1,760 shares of the company’s stock, valued at $358,723.20. The disclosure for this purchase can be found here. Insiders have sold 3,100 shares of company stock valued at $637,463 in the last ninety days. 2.39% of the stock is currently owned by insiders.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply